A detailed history of Hobbs Group Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hobbs Group Advisors, LLC holds 3,471 shares of VRTX stock, worth $1.74 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
3,471
Previous 2,873 20.81%
Holding current value
$1.74 Million
Previous $1.17 Billion 39.17%
% of portfolio
0.62%
Previous 0.52%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$392.81 - $485.53 $234,900 - $290,346
598 Added 20.81%
3,471 $1.63 Billion
Q4 2023

Feb 16, 2024

BUY
$343.0 - $410.68 $985,439 - $1.18 Million
2,873 New
2,873 $1.17 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hobbs Group Advisors, LLC Portfolio

Follow Hobbs Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hobbs Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hobbs Group Advisors, LLC with notifications on news.